Effects of kw-3902, a selective and potent adenosine a1 receptor antagonist, on renal hemodynamics and urine formation in anesthetized dogs

Pharmacology

Volumn 55, Issue 4, 1997, Pages 193-201

  Aki, Yasuharu ^a   Tomohiro, Atsufumi ^a   Nishiyama, Akira ^a   Kiyomoto, Kayo ^a   Kimura, Shoji ^a   Abe, Youichi ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Adenosine A1 receptor antagonist; Renal hemodynamics; Renin angiotensin system; Urine flow

Indexed keywords

8 (2 NOR 1 ADAMANTYL) 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; CANDESARTAN; SODIUM;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIURETIC ACTIVITY; DOG; FEMALE; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; NONHUMAN; OSMOTIC DIURESIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENAL ARTERY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM URINE LEVEL; URINARY EXCRETION; VASOCONSTRICTION;

ADENOSINE; ANESTHESIA; ANIMALS; DIURETICS; DOGS; FEMALE; FUROSEMIDE; HEMODYNAMIC PROCESSES; KIDNEY; MALE; RECEPTORS, PURINERGIC P1; URINATION; VASOCONSTRICTION; XANTHINES;

EID: 0030659097     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139528     Document Type: Article

References (30)

1. Spielman WS, Thompson CI: A proposed role for adenosine in the regulation of renal hemodynamics and renin release. Am J Physiol 1982; 242:F423-F435.
2. Spielman WS; Arend LJ: Adenosine receptors and signaling in the kid-nev. Hypertension 1991; 17:117-130.
3. Tagawa H. Vander AJ: Effects of adenosine compound on renal function and renin secretion in dogs. Circ Res 1970;26:327-338.
4. Osswald H. Spielman WS. Knox FG: Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs. Circ Res 1978;43: 465-469.
5. Aki Y, Shoji T. Hasui K. Fukui K. Tamaki T. Iwao H. Abe Y: lntrare-nal vascular sites of action of adenosine and glucagon. Jpn J Pharmacol 1990;54:433-440.
6. Murray RD. Churchill PC: Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonist. J Pharmacol Exp Ther 1985;232:189-193.
7. LeHir M, Dubach UC: Sodium gradient-energized concentrativc transport of adenosine in renal brush border vesicles. Pfliigers Arch 1984: 401:58-63.
8. Miyamoto M. Yagil Y, Larson T, Robertson C. Jamison RL: Effect of intrarenal adenosine on renal function and medullary blood flow in the rat. Am J Physiol 1988;255:F1230-F1234.
9. Yagil Y: The effects of adenosine on water and sodium excretion. I Pharmacol Exp Ther 1993:268:826-835.
10. Kuan C-J, Herzer WA, Jackson EK: Cardiovascular and renal effects of blocking Ai adenosine receptors. J Cardiovasc Pharmacol 1993:21: 822-828.
11. Mizumoto H. Karasawa A: Renal tubular site of action of KW-3902, a novel adenosine A-rcccptor antagonist. in anesthetized rats. Jpn J Pharmacol 1993;61:251-253.
12. Knight RJ. Bowmer CJ. Yates MS: The diuretic action of 8-cycIopcntyl-1.3-dipropylxanthine, a selective Ai adenosine receptor antagonist. Br J Pharmacol 1993;109:271-277.
13. Cai H. Baluman V. Puschett DB. Puschctt JB: Effect of KW-3902, a novel adenosine AI receptor antagonist, on sodium-dependent phosphate and glucose transport by the rat renal proximal tubular cell. Life Sci 1994;55:839-845.
14. Londos C, Cooper DMF, Woif TJ: Subclasses of cxiernal adenosine receptors. Proc Natl Acad Set USA 1980:77:2551-2554.
15. Van Calker D. Muller M, Ham-precht B: Adenosine regulates via two different receptors the accumulation of cyclic AMP in cultured brain cells. J Neurochcm 1979:33: 999-1005.
16. Kobayashi T. Mizumoto H, Karasa-wa A: Diuretic effects of KW-3902 (8-(noradamantan-3-yl)-1.3-dipro-pylxanthine). a novel adenosine Ai receptor antagonist, in conscious dogs. Biol Pharrn Bull 1993; 16: 1231-1235.
17. Yamagata T. Kobayashi T. Kusaka H, Karasawa A: Diuretic effects of KW-3902, a novel adenosine Ai-receptor antagonist, in anesthetized dogs. Biol Pharrn Bull 1994:17: 1599-1603.
18. Oken DH: An analysis of glomerular dynamics in rat. dog, and man. Kidney Int 1982:22:136-145.
19. Shimada J, Suzuki F, Nonaka H. Ishii A: 8-Polycycloalkyl-1.3-dipro-pylxanthines as potent and selective antagonists for A-adcnosine receptors. J Med Chem 1992:35:924-930.
20. Kusaka H. Karasawa A: Effects of repeated administration of KW-3902. a novel adenosine Ai-rceeptor antagonist, on its pharmacological actions. Jpn J Pharmacol 1993:63: 513-519.
21. Mizumoto H, Karasawa A, Kubo K: Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-d ipro-pylxanthinc (KW-3902). a novel adenosine A-receplor antagonist, via pertussis toxin insensitive mechanism. J Pharmacol Exp Ther 1993; 266:200-206.
22. Munger KA. Jackson EK: Effects of selective Ai receptor blockade on glomerular hemodynamics: Involvement of renin-angiotensin system. Am J Physiol 1994:267:F783-F790.
23. He H. Tamaki T. Tomohiro A. Kita T, Aki Y, Kimura S. Abe Y: Effects of CV-11974 on renal hemodynamics and renal function in dogs. Blood Press 1994;3(suppl 5):79-83.
24. Bonsnes RW, Taussky HH: On the colorimetric determination of creatinine by the Jaffé reaction. J Biol Chem 1945:158:581-591.
25. Osswald H. Schmitz H-J. Kemper R: Tissue content of adenosine, ino-sine and hypoxanthine in the rat kidney after ischemia and postisch-emic recirculation. Ptliigcrs Arch 1977:371:45-49.
26. Miller WL, Thomas RA, Berne RM. Rubio R: Adenosine production in the ischemic kidney. Circ Res 1978: 43:390-397.
27. Takeda M. Yoshitomi K. Imai M: Regulation of Na*-3HCOl cotransport in rabbit proximal convoluted tubule via adenosine A receptor. Am J Physiol 1993;265:F511-F5I9.
28. Vander AJ: Control of renin release. Physiol Rev 1967:47:359-382.
29. Ito S. Carretero OA: Role of the macula densa in renin release. Hypertension 1985;7:149-154.
30. Collis MG, Shaw G, Kcddic JR: Diuretic and saliurctic effects of 1.3-dipropyl-8-cyclopentylxanthinc, a selective A-adenosine receptor antagonist. J Pharrn Pharmacol 1991: 43:138-139.